To view this email as a web page, click here.

In this issue of Dermatology Times, we feature pediatric dermatology research, beginning with advances in junctional epidermolysis bullosa that led to the development of new skin for one young patient.
 
Dermatology Times cover
Dermatology Times cover
EB's Great Hope
In November 2017, Nature published the case of a seven-year-old boy with junctional epidermolysis bullosa who received new sheets of skin developed with stem cell and gene therapy techniques. In this article, pediatricians react to the successful study and address the promise it holds for patients.
Learn more.
 
Pediatric dermatology updates
Drs. Lawrence Eichenfield and Jessica Sprague review some of the most significant findings and developments in pediatric dermatology from the last year, beginning with the availability of biologic agents for pediatric psoriasis and atopic dermatitis.
Learn more.
 
Moisturizing: False claims and problematic ingredients
In this issue we take a close look at the perplexing array of moisturizer options. Choice ultimately comes down to patient preference, but ingredients matter, experts say (pg 64). In this month's table (pg 112), we highlight false claims and problematic ingredients in moisturizers as addressed in JAMA Dermatology.
Learn more.
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.